Quest Diagnostics on Monday launched the first direct-to-consumer blood test to detect abnormal levels of beta amyloid, a key Alzheimer's disease protein that can appear years before dementia ...

Quest Diagnostics (NYSE:DGX) announced on Wednesday that it will roll out a rapid molecular lab test to detect the avian influenza A H5 virus. This initiative is part of an award from the U.S ...

Quest Diagnostics DGX recently received the FDA’s Breakthrough Device Designation for its Adeno-associated virus, AAVrh74 ELISA assay (CDx). The company also announced an expanded collaboration ...

Quest Diagnostics' new transplant support services aim to expedite test results, offer at-home lab draws By Anastassia Gliadkovskaya Apr 4, 2023 4:25pm ...

Quest Diagnostics Inc. said Monday the first blood-based biomarker test to assess the risk of developing Alzheimer’s disease is now available for consumer purchase.

Quest Diagnostics Inc resolved allegations that its prenatal DNA tests infringed a patent owned by biotech company Ravgen Inc on Friday shortly before a trial in Los Angeles federal court was set ...

Medicare covers many tests at Quest Diagnostics — as long as your doctor and Quest location participate in Medicare and the test you're getting is medically necessary. Learn more.

Quest Diagnostics has launched its first consumer-initiated genetic test, Genetic Insights, exclusively available through the company's consumer health business at questhealth.com. - QUEST DIAGNOSTICS ...

During the first rollout of tests in March 2020, before rapid over-the-counter tests were available, Quest Diagnostics experienced a backlog of 160,000 samples to be tested, according to a company ...

Quest Diagnostics is boosting its capabilities in cancer, paying $300 million to acquire a Johns Hopkins University spinout whose technology identifies cancer cells in order to guide treatment ...